This years' conference on Clinical Trials in CNS, is taking place on the 15th and 16th November 2010 in London, and will bring together leading industry experts to explore the current and future opportunities within CNS drug development. Representing the second largest therapeutic segment of the pharmaceutical market it is also one of the fastest growing. This year the conference aims to cover clinical drug discovery activities, new therapeutic targets, as well as effective CNS drug development strategies and problems encountered in clinical trials, with in-depth discussions and case study presentations from the key industry players.

Key topics under discussion include:

• Biomarkers and Imaging techniques in CNS research
• Latest developments in neurodegenerative diseases
• Overcoming the high rate of attrition in therapeutics
• Advanced clinical research methodologies and modelling techniques
• New approaches to identify potential drugs and therapeutic targets
• Measuring cognition and mental wellbeing in patients

For more information on this conference please visit: www.smi-online.co.uk/2010cnstrials2.asp